Article Correctness Is Author's Responsibility: Trial reports randomized evidence high-dose radiation is effective for men whose prostate cancer has spread

A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy. The phase II trial found that radiation therapy can generate an immune system response not previously believed possible in this type of cancer. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).